Predictions
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.85
28.04.23
28.04.23
€21.78
28.04.24
28.04.24
20.90%
22.04.24
22.04.24
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.95
11.04.23
11.04.23
-
11.04.26
11.04.26
-92.19%
20.11.23
20.11.23
Gore German Office R.estate AG
Start price
Target price
Perf. (%)
€1.16
16.03.23
16.03.23
-
12.04.26
12.04.26
-82.76%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Friedrich Vorwerk Group SE
Start price
Target price
Perf. (%)
€10.92
21.02.23
21.02.23
€17.30
27.07.24
27.07.24
42.86%
26.04.24
26.04.24
Dermapharm Holding SE
Start price
Target price
Perf. (%)
€39.44
12.01.23
12.01.23
€60.00
12.01.26
12.01.26
-20.26%
26.04.24
26.04.24
Village Farms Internat. Inc.
Start price
Target price
Perf. (%)
€2.11
07.11.22
07.11.22
-
07.11.25
07.11.25
-40.03%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Top 10 in its market
Weber Inc.
Start price
Target price
Perf. (%)
€13.20
25.10.22
25.10.22
€15.00
-
24.09.21
24.09.21
Could be worthwhile Investment >10% per year
Biohaven Pharmac.hldg Co.ltd.
Start price
Target price
Perf. (%)
€156.00
11.10.22
11.10.22
€160.00
-
03.10.22
03.10.22
Cresco Labs Inc.
Start price
Target price
Perf. (%)
€3.30
19.09.22
19.09.22
-
03.05.24
03.05.24
-41.33%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Revenue growth >5% per year expected
Soltech Energy Sweden Ab
Start price
Target price
Perf. (%)
€1.53
05.09.22
05.09.22
-
29.08.26
29.08.26
-73.47%
25.04.24
25.04.24
Revenue growth >5% per year expected
Probably not worthwhile Investment
Haier Smart Home Co. Ltd.
Start price
Target price
Perf. (%)
€2.94
24.03.22
24.03.22
€4.00
25.03.25
25.03.25
7.24%
25.04.24
25.04.24
Americas Gold & Silver Corp.
Start price
Target price
Perf. (%)
€1.01
24.02.22
24.02.22
€10.00
11.06.25
11.06.25
-73.98%
26.04.24
26.04.24
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Revenue growth >5% per year expected
Innovative